CN1385200A - Lily bulb health care product - Google Patents

Lily bulb health care product Download PDF

Info

Publication number
CN1385200A
CN1385200A CN02114620A CN02114620A CN1385200A CN 1385200 A CN1385200 A CN 1385200A CN 02114620 A CN02114620 A CN 02114620A CN 02114620 A CN02114620 A CN 02114620A CN 1385200 A CN1385200 A CN 1385200A
Authority
CN
China
Prior art keywords
product
health care
lily bulb
care product
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN02114620A
Other languages
Chinese (zh)
Other versions
CN1273048C (en
Inventor
卞敬平
肖永良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021146209A priority Critical patent/CN1273048C/en
Publication of CN1385200A publication Critical patent/CN1385200A/en
Application granted granted Critical
Publication of CN1273048C publication Critical patent/CN1273048C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The lily bulb health-care product is made of the chinese medicinal materials of lily bulb, potentila anserina, lentinus, chrysanthemum flower, lycium berry, poria and jujube. Said invented product contains the polyose nonspecific immunity-enhancing regulators of lily glycoside, lentinan, Chinese wolfberry polysaccharide and poria polysaccharide, so that it has the functions of reducing blood sugar, reducing blood fat, resisting blood coagulation and resisting cancers.

Description

Lily bulb health care product
Technical field
The present invention relates to a kind of health product of making by wholefood, refer to a kind of lily bulb health care product especially.
Background technology
Bulbus Lilii is with a long history China's cultivation, and kind is kind surplus in the of 60 nearly, and having only lanzhou lily, Hunan Bulbus Lilii, Yixing Bulbus Lilii is China's good merchantable brand, and latter two kind is because the plantation amount is few, and bitter in the mouth, light is only done and is used as medicine.Lanzhou lily is the underground bulb of liliaceous plant Bulbus Lilii, it is the unique edible sweet Bulbus Lilii of China, its bulb is very large, cuiller is plump, as white as polished jade, meat is fine and smooth, unique local flavor, nutritious, the various nutrient substance that contain needed by human body, the analysis showed that, Bulbus Lilii contains carbohydrate (starch), protein, calcium, phosphorus, ferrum and vitamin C, vitamin B group, pantothenic acid, carotene etc.
The traditional Chinese medical science is thought its sweet-bitter flavor of Bulbus Lilii, cold nature and moisten GUIXIN, lung meridian.Nourishing the lung to arrest cough, replenishing YIN and removing heat arranged, clear away heart-fire with fixed attention, the effect of sharp defecation, invigorating the spleen and replenishing QI.
The modern biomedical technology proves that alkaloids such as the Bulbus Lilii glycoside in the Bulbus Lilii can suppress the growth of murine sarcoma, cervical cancer, and acetone extract can significantly suppress the mutagenic action of aflatoxin, and the effect of prevention hepatocarcinoma is arranged.
Of the present invention open
The objective of the invention is for a kind of regulator that contains the non-specific enhance immunity of polysaccharide such as Bulbus Lilii glycoside, lentinan, lycium barbarum polysaccharide, pachyman is provided, and have several physiological active substances such as blood sugar lowering, blood fat reducing, anticoagulation and have the lily bulb health care product of significantly anticancer polyglucose class bioactive substance.
Purpose of the present invention can realize by following measure:
A kind of lily bulb health care product is to be made by the raw material of the following weight parts dosage form preparation technology by known health product: Bulbus Lilii 100-800 part, Radix potentillae anserinae 50-600 part, Lentinus Edodes 50-600 part, Flos Chrysanthemi 10-400 part, Fructus Lycii 10-500 part, Poria 50-600 part, Fructus Jujubae 20-200 part.
The dosage form of described health product is any dosage form of health product.
Described dosage form is oral liquid, electuary, capsule, tablet.
A kind of preparation technology of lily bulb health care product carries out described raw material after water carries with 1500-2000 part water by the compatibility of its described weight portion, it is 8-18 that its water extract is concentrated into Baume degrees, and the Mel that adds the 15-30% of its total amount again in concentrated solution is promptly made oral liquid.
A kind of preparation technology of lily bulb health care product will adopt CO behind the compatibility of described raw material by its described weight portion 2Supercritical extraction and extraction process by water collection are carried the back and are made by known health product dosage form.
The invention has the advantages that:
The present invention is primary raw material with the Bulbus Lilii, is equipped with Radix potentillae anserinae, Lentinus Edodes, Fructus Lycii, Flos Chrysanthemi, Poria, Fructus Jujubae again, by the modern biotechnology means, extracts the active ingredient and the nutrition component that immune function of human body there are biological effect; Alkaloids such as the Bulbus Lilii glycoside in the product of the present invention can suppress the growth of murine sarcoma, cervical cancer, and acetone extract can significantly suppress the mutagenic action of aflatoxin, the effect of prevention hepatocarcinoma is arranged, thereby the present invention have tangible antitumaous effect.Also contain polysaccharose substances such as lentinan, lycium barbarum polysaccharide, pachyman in the product of the present invention in addition, it is a kind of regulator of non-specific enhance immunity, and be the material with multiple physiologically actives such as blood sugar lowering, blood fat reducing, anticoagulations, also can significantly improve the human body antifatigue effect.Its effect can confirm by following experiment:
Military three team members assemble for training to move under high altitude environment and hinder pilosity, particularly after entering height above sea level 2366m environmental training, male player's testosterone/hydrocortisone ratio rising (P<0.01), woman team member is also in rising trend, pointed out catabolism to be greater than anabolism, sports fatigue has begun accumulation, training achievement also has been subjected to influence, under the situation of using various conventional measure poor effect, the team member has taken homemade product of the present invention, achieve good results, enzyme in men and women team member's blood before and after now drinking, the variation of protein and testosterone levels etc. is reported as follows: 1. outstanding military three team members of object and method 1.1 objects 35, wherein the man is 15,10 of woman, age 19-21 year.1.2 the instructions of taking of product of the present invention: the product 50ml of the present invention that has prepared, 3 times/day, ante cibum is oral, takes a cycle of training (30 days).1.3 blood sampling time: gather respectively take before, take after a cycle of training venous blood 5ml on an empty stomach in morning, separation of serum-40 ℃ preservation is to be measured.1.4 detecting instrument uses U.S. Beckman CX-5 Automatic Series biochemistry analyzer, the mensuration project is: lactic acid dehydrogenase (LDH), alpha-hydroxybutyric dehydrogenase (α-HBDH), creatine creatase (CK), creatine creatase-MB (CK-MB), glutamic oxaloacetic transaminase, GOT (GOT), glutamate pyruvate transaminase (GPT), alkali phosphatase (ALP), gamma glutamyl transpeptidase (GGT) etc., and total serum protein (TP), albumin (Alb), globulin (Glob), Archon ratio (A/G) flesh liver (Cr), RBC, Hb adopts Switzerland's blood cell analyser, and testosterone (T) uses radio immunoassay mensuration etc.2. it is as follows that result 2.1 men and women team members take product of the present invention front and rear part enzymic change:
Men and women team member's enzyme all has obvious variation, the man has downward trend except that GOT, ALP and the not statistically significant (P>0.05), every all have highly significant or significance meaning (P<0.01, P<0.05) descends, the woman has downward trend except that GPT but the not statistically significant (P>0.05), the decline of all enzymes all has the difference (p<0.01, P<0.05) of highly significant or significance.2.2 it is as follows that men and women team member takes before and after the product of the present invention the variation of PT, Cr etc.: men and women team member's TP, Alb, and woman's A/G, Cr all on the rise, significant differences or the significance difference opposite sex (P<0.01 are arranged, P<0.05), men and women's Glob, and man's A/G, Cr value surface see on the rise, but not statistically significant.2.3 men and women team member takes T, Hb in the product bleeding from anus of the present invention, the RBC situation of change is as follows: every index is all on the rise before and after using, men and women team member's T, RBC all have significant differences (P<0.001, P<0.01), female team member Hb has significant difference (P<0.05), male team member Hb not statistically significant (P>0.05).3. the reparation of 3.1 muscle injury is discussed: myopathy is that the myocyte damages, and the diagnosis of myopathy is determined or got rid of to the level that can discharge some enzyme from measure serum in the myocyte, and it is muscle injury the most special the most responsive qualitative index that the creatine creatase raises.This observation be at the every observation index of crew all in crowd's normal reference value, carry out under the normal situation of electrocardiogram, from downward trend of taking each zymogram of product of the present invention front and back and the situation that training achievement, endurance all are significantly improved and improve, illustrate that there is the objectivity that causes muscle injury behind the exacting practice in the team member, take the effect of the resisting kinetic fatigue that has reached certain behind the product of the present invention, the damage in each zymogram downward trend explanation myocyte is necessarily controlled and is repaired.3.2 the detoxifcation of liver and protein synthesis capacity strengthen.After taking product of the present invention, total protein, albumin, globulin, Archon ratio, flesh liver etc. are all on the rise, and each enzyme of liver function is normal population lower limit trend, testosterone levels raises, particularly the female team member exceeds normal population upper limit several times (p<0.001), and risings such as hemoglobin, red blood cell count(RBC) all have significant difference.The ability that synthetic protein in the body is described is strengthening, and organismic internal environment damages in active remediation.The flesh liver is the metabolite of creatine, its eliminating amount and muscle total amount, and body surface area is closely related with body weight, do not infused and influence that body fluid storage is stayed, than nitrogen balance, index sensitivities such as serum albumin.Protein malnutrition, during the wound wasting diseases, muscular tissue is decomposed reinforcement, and the protein deposit descends, amyotrophy, flesh liver growing amount reduces.This is observed and finds that men and women team member's flesh liver all has the trend (P<0.01, P<0.05) of rising.Think take product of the present invention after; the trend of the oriented positive nitrogen balance development of Proteometabolism; show also simultaneously that occur being not in good state in the training early stage; achievement descends relevant with the sports fatigue that has potentiality; product of the present invention possesses the removing interior metabolism product; repair the effect of damage and synthetic protein, also possess protection conscience kidney and muscle fiber function.3.3 endogenous gonadal hormone: after taking product of the present invention, the rising of testosterone, red blood cell count(RBC) illustrates that this product has the function of stimulation of endogenous sex hormones secretion in the blood, improves testosterone levels and strengthens hemopoietic.
The specific embodiment
The present invention also will be described in further detail embodiment:
Embodiment one:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 790 parts of Bulbus Liliies, 55 parts of Radix potentillae anserinae, 250 parts on Lentinus Edodes, 50 parts of Flos Chrysanthemis, 100 parts of Fructus Lyciis, 250 parts in Poria, 30 parts of Fructus Jujubaes.
Its preparation technology adds 1600 parts of water to carry out after water carries after above-mentioned Bulbus Lilii, Radix potentillae anserinae, Lentinus Edodes, Flos Chrysanthemi, Fructus Lycii, Poria, Fructus Jujubae are mixed by its weight portion, extracting solution is concentrated into 1500 parts adds 300 parts of Mel again and add deionized water to 2000 and part promptly make oral liquid.
Embodiment two:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 120 parts of Bulbus Liliies, 550 parts of Radix potentillae anserinae, 60 parts on Lentinus Edodes, 380 parts of Flos Chrysanthemis, 450 parts of Fructus Lyciis, 60 parts in Poria, 100 parts of Fructus Jujubaes.
Its preparation technology adopts CO with raw material 2Supercritical process comes together and carries, and make by known health product technology dosage form the back.
Embodiment three:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 500 parts of Bulbus Liliies, 100 parts of Radix potentillae anserinae, 550 parts on Lentinus Edodes, 20 parts of Flos Chrysanthemis, 50 parts of Fructus Lyciis, 450 parts in Poria, 150 parts of Fructus Jujubaes.
Embodiment four:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 300 parts of Bulbus Liliies, 320 parts of Radix potentillae anserinae, 130 parts on Lentinus Edodes, 200 parts of Flos Chrysanthemis, 250 parts of Fructus Lyciis, 550 parts in Poria, 60 parts of Fructus Jujubaes.
Embodiment five:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 650 parts of Bulbus Liliies, 210 parts of Radix potentillae anserinae, 380 parts on Lentinus Edodes, 120 parts of Flos Chrysanthemis, 350 parts of Fructus Lyciis, 130 parts in Poria, 180 parts of Fructus Jujubaes.
Embodiment six:
A kind of lily bulb health care product is to be made by known oral liquid technology by the raw material of following weight parts: 220 parts of Bulbus Liliies, 400 parts of Radix potentillae anserinae, 450 parts on Lentinus Edodes, 310 parts of Flos Chrysanthemis, 30 parts of Fructus Lyciis, 350 parts in Poria, 120 parts of Fructus Jujubaes.

Claims (5)

1, a kind of lily bulb health care product is characterized in that it is to be made by the raw material of the following weight parts dosage form preparation technology by known health product:
Bulbus Lilii 100-800 part Radix potentillae anserinae 50-600 part Lentinus Edodes 50-600 part
Flos Chrysanthemi 10-400 part Fructus Lycii 10-500 part Poria 50-600 part
Fructus Jujubae 20-200 part.
2, lily bulb health care product as claimed in claim 1, the dosage form that it is characterized in that described health product are any dosage form of health product.
3, lily bulb health care product as claimed in claim 1 is characterized in that described dosage form is oral liquid, electuary, capsule, tablet.
4, the preparation technology of lily bulb health care product as claimed in claim 1, it is characterized in that described raw material is carried out after water carries with 1500-2000 part water by the compatibility of its described weight portion, it is 8-18 that its water extract is concentrated into Baume degrees, and the Mel that adds the 15-30% of its total amount again in concentrated solution is promptly made oral liquid.
5, the preparation technology of lily bulb health care product as claimed in claim 1 is characterized in that and will adopt CO behind the compatibility of described raw material by its described weight portion 2Supercritical extraction and extraction process by water collection are carried the back and are made by known health product dosage form.
CNB021146209A 2002-05-31 2002-05-31 Lily bulb health care product Expired - Fee Related CN1273048C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021146209A CN1273048C (en) 2002-05-31 2002-05-31 Lily bulb health care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021146209A CN1273048C (en) 2002-05-31 2002-05-31 Lily bulb health care product

Publications (2)

Publication Number Publication Date
CN1385200A true CN1385200A (en) 2002-12-18
CN1273048C CN1273048C (en) 2006-09-06

Family

ID=4743193

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021146209A Expired - Fee Related CN1273048C (en) 2002-05-31 2002-05-31 Lily bulb health care product

Country Status (1)

Country Link
CN (1) CN1273048C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305381C (en) * 2005-07-20 2007-03-21 汝源 Cake contg. jujube kernel and lily bulb and making technique thereof
CN102224895A (en) * 2011-05-09 2011-10-26 兰州甜甜百合有限公司 Production method of inulin lily granules
CN102440388A (en) * 2010-11-26 2012-05-09 董义斌 Health-care product for reducing blood fat and reducing blood sugar
CN101637255B (en) * 2009-08-19 2013-01-09 王寿光 Hypoglycemic nutrition powder
CN103734581A (en) * 2014-01-23 2014-04-23 甘南倍益特生物科技有限公司 Yak lactoprotein polypeptide nutrition powder applicable to rehabilitation of people after operations and preparation method of powder
CN104161243A (en) * 2014-09-01 2014-11-26 苗娥 Silverweed cinquefoil root health-maintaining powder and preparation method thereof
CN110917291A (en) * 2019-12-12 2020-03-27 江苏康缘药业股份有限公司 Composition with function of improving immunity and preparation method and application thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305381C (en) * 2005-07-20 2007-03-21 汝源 Cake contg. jujube kernel and lily bulb and making technique thereof
CN101637255B (en) * 2009-08-19 2013-01-09 王寿光 Hypoglycemic nutrition powder
CN102440388A (en) * 2010-11-26 2012-05-09 董义斌 Health-care product for reducing blood fat and reducing blood sugar
CN102440388B (en) * 2010-11-26 2013-08-21 董义斌 Health-care product for reducing blood fat and reducing blood sugar
CN102224895A (en) * 2011-05-09 2011-10-26 兰州甜甜百合有限公司 Production method of inulin lily granules
CN103734581A (en) * 2014-01-23 2014-04-23 甘南倍益特生物科技有限公司 Yak lactoprotein polypeptide nutrition powder applicable to rehabilitation of people after operations and preparation method of powder
CN103734581B (en) * 2014-01-23 2015-08-26 甘南倍益特生物科技有限公司 Yak milk polypeptide nutrient powder being applicable to postoperative crowd's rehabilitation and preparation method thereof
CN104161243A (en) * 2014-09-01 2014-11-26 苗娥 Silverweed cinquefoil root health-maintaining powder and preparation method thereof
CN110917291A (en) * 2019-12-12 2020-03-27 江苏康缘药业股份有限公司 Composition with function of improving immunity and preparation method and application thereof

Also Published As

Publication number Publication date
CN1273048C (en) 2006-09-06

Similar Documents

Publication Publication Date Title
CN101491334B (en) Health food with immunity reinforcement function
CN103462037B (en) A kind of natural additive for foodstuff
CN101965969B (en) Health-care food composition with anti-fatigue and immunity-improving functions and preparation method and application thereof
CN107581619A (en) A kind of antifatigue anti senility sea cucumber oyster peptide complex capsule and preparation method thereof
CN103860580B (en) It is a kind of have strengthen the body resistance to consolidate the constitution, the composite fungi amylose preparation of strengthening the spleen and stomach, strengthen immunity function
CN102511710B (en) Low energy nutrition powder
CN106473107A (en) A kind of instant type composite edible mycopowder nutrient and preparation method thereof
CN108185339A (en) The beautiful enzyme composition of promise and its preparation
CN101579120A (en) Nutritional food with weight-losing function and preparation method thereof
CN102488278A (en) Composite fungus nutrient solution with bifunctional health care effect
CN104479968A (en) Purple sweet potato health wine
CN110192583A (en) With the composition and application for promoting intestinal health, control weight and raising to be immunized
CN103704711B (en) Granules with anti-fatigue and health-care function
CN1273048C (en) Lily bulb health care product
CN104857334A (en) Hypoglycemic wine and preparation method thereof
CN1094892A (en) Shouxian cake
CN101120750B (en) Method for preparing ginkgo bee product
CN103349079B (en) A kind of production method of functional milk beverage with cepe
CN112120215A (en) Diet suitable for gout and hyperuricemia people
CN111387394A (en) Sea-buckthorn solid beverage for enhancing immunity and inhibiting tumors and preparation method thereof
CN104757667A (en) Beverage and preparation method thereof
CN108991498A (en) Ferment and preparation method thereof
CN101336721A (en) Health beverage and its preparation method
CN107223966A (en) It is a kind of to be used to improve sweet oral liquid of Rong's grass of immunity and preparation method thereof
CN106074799A (en) A kind of production method of Xinhui citrus reticulata edible fungi ferment

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060906

Termination date: 20120531